INLYTA (axitinib) tablets
INLYTA is a brand-name prescription medication that’s used to treat reast cancer, Cervical cancer, Classic Hodgkin lymphoma, Cutaneous squamous cell carcinoma (a type of skin cancer), Endometrial carcinoma, Esophageal or gastroesophageal junction cancer and more. Brand Name: INLYTA (axitinib) tablets for oral administration Initial U.S. Approval: 2012
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Overseas Patient/ Export inquires.
Call / WhatsApp Number
+91 9643240915 (Mr. Yashpal Singh)
+91 9289711087 (Ms. Sana Sadyar)
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
INLYTA (axitinib) tablets
Axitinib is approved to treat: Renal cell carcinoma. Axitinib is also being studied in the treatment of other types of cancer.
INLYTA, A drug used alone or with other drugs to treat advanced renal cell carcinoma (a type of kidney cancer). It is used in patients whose cancer has not already been treated or whose cancer has not gotten better after treatment with one other systemic therapy. It is also being studied in the treatment of other types of cancer. Inlyta blocks proteins called growth factor receptors, which may help keep cancer cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow. Inlyta is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called axitinib.
Axitinib, A drug used alone or with other drugs to treat advanced renal cell carcinoma (a type of kidney cancer). It is used in patients whose cancer has not already been treated or whose cancer has not gotten better after treatment with one other systemic therapy. It is also being studied in the treatment of other types of cancer. Axitinib blocks proteins called growth factor receptors, which may help keep cancer cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow. Axitinib is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called Inlyta. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/axitinib
Drug (Brand / Generic): INLYTA / axitinib tablets
Current Indications: Renal cell carcinoma
Marketed by:: Pfizer, Inc
Approval Date: 2012
Available as (Form & Strength): 1 mg and 5 mg tablet
For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier / importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “INLYTA (axitinib) tablets”.
Confirmation of the order for INLYTA (axitinib) tablets will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
We have delivered medicines to following cities in India – Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha
ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand INLYTA (axitinib) tablets. The import process requires a valid prescription and an Import License in the Patient’s Name.
For patients from following foreign countries seeking access to INLYTA (axitinib) tablets, they can inquire and find further information by sending their inquiries to ALS.
We have delivered medicines to following countries – Argentina, Australia, Austria, Azerbaijan, Bahrain, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cyprus, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, India, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malawi, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sri Lanka, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Zimbabwe.
Kindly reach out to us for INLYTA (axitinib) tablets price and availability confirmation.
The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.
